Literature DB >> 30867803

ZFP91 zinc finger protein expression pattern in normal tissues and cancers.

Lukasz Paschke1, Karol Jopek1, Marta Szyszka1, Marianna Tyczewska1, Ludwik K Malendowicz1, Marcin Rucinski1.   

Abstract

Zinc finger protein 91 (ZFP91) gene has been recently acknowledged to possess oncogenic properties. To date, its expression has been examined only in a handful of human organs and cancer types. The aim of the present study was to characterize, for the first time, the ZFP91 expression pattern in a range of human tissues and cancer types. ZFP91 mRNA expression was examined using Cancer Survey cDNA sets. Utilized cDNA samples represented 15 human organs and 17 cancer types. ZFP91 mRNA expression was the highest in the testes and lymph nodes. It was downregulated in testis cancer, lymphoma and thyroid cancer, and upregulated in prostate cancer. Among the analyzed cancer types, ZFP91 expression was markedly elevated in sarcomas and melanoma. On a protein level, a large-scale reverse phase protein array was employed providing samples from 11 organ types and from cancers derived from these organs. ZFP91 protein expression was revealed to be generally stable across the tested samples and was only moderately elevated in breast, ovarian and pancreatic cancers. To the best of our knowledge, this is the first study to thoroughly analyze the ZFP91 expression pattern in human tissues and cancers. The obtained results provide the foundation for further work aiming to reveal its full biological significance.

Entities:  

Keywords:  cancer pathogenesis; hypoxia inducible factor-1α; nuclear factor-κB; zinc finger protein 91

Year:  2019        PMID: 30867803      PMCID: PMC6396258          DOI: 10.3892/ol.2019.9963

Source DB:  PubMed          Journal:  Oncol Lett        ISSN: 1792-1074            Impact factor:   2.967


  2 in total

1.  Overcoming IMiD resistance in T-cell lymphomas through potent degradation of ZFP91 and IKZF1.

Authors:  Wenchao Wu; Geoffrey M Nelson; Raphael Koch; Katherine A Donovan; Radosław P Nowak; Tayla B Heavican-Foral; Ajit J Nirmal; Huiyun Liu; Lei Yang; Jessica Duffy; Foster Powers; Kristen E Stevenson; Marcus Kenneth Jones; Samuel Y Ng; Gongwei Wu; Salvia Jain; Ran Xu; Sam Amaka; Christopher Trevisani; Nicholas L Donaldson; Patrick R Hagner; Laurence de Leval; Philippe Gaulard; Javeed Iqbal; Anjan Thakurta; Eric S Fischer; Karen Adelman; David M Weinstock
Journal:  Blood       Date:  2022-03-31       Impact factor: 25.476

2.  MicroRNA‑188‑5p inhibits the progression of breast cancer by targeting zinc finger protein 91.

Authors:  Zhiguang Yang; Zhaoyu Liu; Zhihui Chang; Guangxin Yan
Journal:  Oncol Rep       Date:  2020-08-12       Impact factor: 3.906

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.